<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39049549</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus D68 disease burden and epidemiology in hospital-admitted influenza-like illness, Valencia region of Spain, 2014-2020 influenza seasons.</ArticleTitle><Pagination><StartPage>e29810</StartPage><MedlinePgn>e29810</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29810</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is an emerging agent for which data on the susceptible adult population is scarce. We performed a 6-year analysis of respiratory samples from influenza-like illness (ILI) admitted during 2014-2020 in 4-10 hospitals in the Valencia Region, Spain. EV-D68 was identified in 68 (3.1%) among 2210 Enterovirus (EV)/Rhinovirus (HRV) positive samples. Phylogeny of 59 VP1 sequences showed isolates from 2014 clustering in B2 (6/12), B1 (5/12), and A2/D1 (1/12) subclades; those from 2015 (n = 1) and 2016 (n = 1) in B3 and A2/D1, respectively; and isolates from 2018 in A2/D3 (42/45), and B3 (3/45). B1 and B2 viruses were mainly detected in children (80% and 67%, respectively); B3 were equally distributed between children and adults; whereas A2/D1 and A2/D3 were observed only in adults. B3 viruses showed up to 16 amino acid changes at predicted antigenic sites. In conclusion, two EV-D68 epidemics linked to ILI hospitalized cases occurred in the Valencia Region in 2014 and 2018, with three fatal outcomes and one ICU admission. A2/D3 strains from 2018 were associated with severe respiratory infection in adults. Because of the significant impact of non-polio enteroviruses in ILI and the potential neurotropism, year-round surveillance in respiratory samples should be pursued.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mengual-Chuliá</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7605-8175</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamayo-Trujillo</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9059-3281</Identifier><AffiliationInfo><Affiliation>Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira-Iglesias</LastName><ForeName>Ainara</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6371-8229</Identifier><AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cano</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4550-2819</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Esteban</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3745-5757</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrús</LastName><ForeName>Maria Loreto</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-5739-2063</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puig-Barberà</LastName><ForeName>Joan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5783-0409</Identifier><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díez-Domingo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1008-3922</Identifier><AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-Labrador</LastName><ForeName>F Xavier</ForeName><Initials>FX</Initials><Identifier Source="ORCID">0000-0002-9403-8258</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Ecology, Medical School, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>VAHNSI network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="Y">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV‐D68 epidemics</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">adults</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">hospitalizations</Keyword><Keyword MajorTopicYN="N">influenza‐like illness</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Carballido-Fernández</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital General de Castelló, Castelló, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mollar-Maseres</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tortajada-Girbés</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Doctor Peset, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schwarz-Chávarri</LastName><ForeName>Germán</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital General de Alicante, Alicante, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Limón-Ramírez</LastName><ForeName>Ramón</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital La Plana, Vila-real, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carbonell-Franco</LastName><ForeName>Empar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Arnau de Vilanova, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belenguer-Varea</LastName><ForeName>Ángel</ForeName><Initials>Á</Initials><AffiliationInfo><Affiliation>Hospital de La Ribera, Alzira, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tuells-Hernández</LastName><ForeName>José Vicente</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Hospital de Torrevieja, Torrevieja and Hospital del Vinalopó, Elche, Spain.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>25</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39049549</ArticleId><ArticleId IdType="doi">10.1002/jmv.29810</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Joffret M‐L, Polston PM, Razafindratsimandresy R, Bessaud M, Heraud J‐M, Delpeyroux F. Whole genome sequencing of enteroviruses species A to D by high‐throughput sequencing: application for viral mixtures. Front Microbiol. 2018;9:2339.</Citation></Reference><Reference><Citation>Sun J, Hu XY, Yu XF. Current understanding of human enterovirus D68. Viruses. 2019;11:490.</Citation></Reference><Reference><Citation>Simmonds P, Gorbalenya AE, Harvala H, et al. Recommendations for the nomenclature of enteroviruses and rhinoviruses. Arch Virol. 2020;165:793‐797.</Citation></Reference><Reference><Citation>Simmonds P, Gorbalenya AE, Harvala H, et al. Correction to: aecommendations for the nomenclature of enteroviruses and rhinoviruses (Archives of Virology, (2020), 165, 3, (793‐797), 10.1007/s00705‐019‐04520‐6. Arch Virol. 2020;165:1515.</Citation></Reference><Reference><Citation>Chen BS, Lee HC, Lee KM, Gong YN, Shih SR. Enterovirus and encephalitis. Front Microbiol. 2020;11:261.</Citation></Reference><Reference><Citation>Cramer N, Munjal N, Ware D, et al. New cluster of acute flaccid myelitis in Western Pennsylvania. Ann Emerg Med. 2019;74:503‐508.</Citation></Reference><Reference><Citation>Hixon AM, Frost J, Rudy MJ, Messacar K, Clarke P, Tyler KL. Understanding enterovirus D68‐induced neurologic disease: a basic science review. Viruses. 2019;11:821.</Citation></Reference><Reference><Citation>Uprety P, Curtis D, Elkan M, et al. Association of enterovirus D68 with acute flaccid myelitis, Philadelphia, Pennsylvania, USA, 2009‐2018. Emerg Infect Dis. 2019;25:1676‐1682.</Citation></Reference><Reference><Citation>Cassidy H, Poelman R, Knoester M, Van leer‐Buter CC, Niesters HGM. Enterovirus D68—the new polio? Front Microbiol. 2018;9:2677.</Citation></Reference><Reference><Citation>Midgley SE, Benschop K, Dyrdak R, et al. Co‐circulation of multiple enterovirus D68 subclades, including a novel B3 cluster, across Europe in a season of expected low prevalence, 2019/20. Euro Surveill. 2020;25:1900749.</Citation></Reference><Reference><Citation>Poelman R, Schuffenecker I, Van Leer‐Buter C, et al European surveillance for enterovirus D68 during the emerging North‐American outbreak in 2014. J Clin Virol. 2015;71:1‐9.</Citation></Reference><Reference><Citation>Knoester M, Helfferich J, Poelman R, Van Leer‐Buter C, Brouwer OF, Niesters HGM. Twenty‐nine cases of enterovirus‐D68‐associated acute flaccid myelitis in Europe 2016: a case series and epidemiologic overview. Pediatr Infect Dis J. 2019;38:16‐21.</Citation></Reference><Reference><Citation>Bal A, Sabatier M, Wirth T, et al. Emergence of enterovirus D68 clade D1, France, August to November 2018. Euro Surveill. 2019;24:1800699.</Citation></Reference><Reference><Citation>Pellegrinelli L, Giardina F, Lunghi G, et al. Emergence of divergent enterovirus (EV) D68 sub‐clade D1 strains, northern Italy, september to october 2018. Euro Surveill. 2019;24:1900090.</Citation></Reference><Reference><Citation>Cottrell S, Moore C, Perry M, Hilvers E, Williams C, Shankar AG. Prospective enterovirus D68 (EV‐D68) surveillance from september 2015 to november 2018 indicates a current wave of activity in Wales. Euro Surveill. 2018;23:1800578.</Citation></Reference><Reference><Citation>Pebody R, Ramsay M, Dunning J, et al. An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 january 2018‐21 january 2019: early findings. Euro Surveill. 2019;24:1900093.</Citation></Reference><Reference><Citation>González‐Sanz R, Taravillo I, Reina J, et al. Enterovirus D68‐associated respiratory and neurological illness in Spain, 2014–2018. Emerg Microbes Infect. 2019;8:1438‐1444.</Citation></Reference><Reference><Citation>Mira‐Iglesias A, Mengual‐Chuliá B, Cano L, et al. Retrospective screening for SARS‐CoV‐2 among influenza‐like illness hospitalizations: 2018–2019 and 2019–2020 seasons, Valencia region, Spain. Influenza Other Respir Viruses. 2022;16:166‐171.</Citation></Reference><Reference><Citation>Puig‐Barberà J, García‐De‐Lomas J, Díez‐Domingo J, et al. Influenza vaccine effectiveness in preventing influenza A(H3N2)‐related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital‐based test‐negative study, 2011‐2012 A(H3N2) predominant influenza season, Valencia, Spain. PLoS One. 2014;9:e112294.</Citation></Reference><Reference><Citation>ECDC. Commission Implementing Decision 2012/506/EU of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Counci [Internet] Official Journal of the European Union; 2012.</Citation></Reference><Reference><Citation>WHO, CDC. Enterovirus Surveillance Guidelines: Guidelines for Enterovirus Surveillance in Support of the Polio Eradication Initiative [Internet]; 2015:140.</Citation></Reference><Reference><Citation>World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191‐2194.</Citation></Reference><Reference><Citation>Puig‐Barberà J, Natividad‐Sancho A, Launay O, et al. 2012‐2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance Network. PLoS One. 2014;9:e100497.</Citation></Reference><Reference><Citation>Tapparel C, Cordey S, Van Belle S, et al. New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J Clin Microbiol. 2009;47:1742‐1749.</Citation></Reference><Reference><Citation>Poelman R, Schölvinck EH, Borger R, Niesters HGM, Van Leer‐Buter C. The emergence of enterovirus D68 in a Dutch University Medical Center and the necessity for routinely screening for respiratory viruses. J Clin Virol. 2015;62:1‐5.</Citation></Reference><Reference><Citation>Staden R. The Staden Sequence Analysis Package. Mol Biotechnol. 1996;5:233‐241.</Citation></Reference><Reference><Citation>Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792‐1797.</Citation></Reference><Reference><Citation>Baez‐Ortega A. mutree: a pipeline for phylogenetic tree inference and recurrent mutation discovery. Zenodo. 2017. doi:10.5281/zenodo.583634</Citation></Reference><Reference><Citation>Tamura K, Stecher G, Kumar S. MEGA11: Molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022‐3027.</Citation></Reference><Reference><Citation>Pedersen TL. ggraph: An Implementation of Grammar of Graphics for Graphs and Networks; 2022.</Citation></Reference><Reference><Citation>Shen L, Gong C, Xiang Z, et al. Upsurge of enterovirus D68 and circulation of the new subclade D3 and subclade B3 in Beijing, China, 2016. Sci Rep. 2019;9:6073.</Citation></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med. 2015;3:879‐887.</Citation></Reference><Reference><Citation>Wang G, Zhuge J, Huang W, et al. Enterovirus D68 subclade B3 strain circulating and causing an outbreak in the United States in 2016. Sci Rep. 2017;7:1242.</Citation></Reference><Reference><Citation>Kramer R, Sabatier M, Wirth T, et al. Molecular diversity and biennial circulation of enterovirus D68: a systematic screening study in Lyon, France, 2010 to 2016. Euro Surveill. 2018;23:1700711.</Citation></Reference><Reference><Citation>Piralla A, Principi N, Ruggiero L, et al. Enterovirus‐D68 (EV‐D68) in pediatric patients with respiratory infection: the circulation of a new B3 clade in Italy. J Clin Virol. 2018;99:91‐96.</Citation></Reference><Reference><Citation>Yip C, Lo J, Sridhar S, et al. First report of a fatal case associated with EV‐D68 infection in Hong Kong and emergence of an interclade recombinant in China revealed by genome analysis. Int J Mol Sci. 2017;18:1065.</Citation></Reference><Reference><Citation>Hodcroft EB, Dyrdak R, Andrés C, et al. Evolution, geographic spreading, and demographic distribution of enterovirus D68. PLoS Pathog. 2022;18:e1010515.</Citation></Reference><Reference><Citation>Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak, Kansas City, Missouri, USA. Emerg Infect Dis. 2019;25:585‐588.</Citation></Reference><Reference><Citation>Mishra N, Ng TFF, Marine RL, et al. Antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis. mBio. 2019;10:e01903‐19.</Citation></Reference><Reference><Citation>Kaida A, Iritani N, Yamamoto SP, et al. Distinct genetic clades of enterovirus D68 detected in 2010, 2013, and 2015 in Osaka City, Japan. PLoS One. 2017;12:e0184335.</Citation></Reference><Reference><Citation>Harvala H, Benschop KSM, Berginc N, et al. European non‐polio enterovirus network: introduction of hospital‐based surveillance network to understand the true disease burden of non‐polio enterovirus and parechovirus infections in Europe. Microorganisms. 2021;9:1827.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>